Australia markets closed

OncoCyte Corporation (OCX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.7600+0.0800 (+2.99%)
At close: 04:00PM EDT
2.7000 -0.06 (-2.17%)
After hours: 05:45PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-0.56-0.55-2.76-2.1
Low estimate-0.68-0.66-3.09-2.58
High estimate-0.44-0.43-2.44-1.63
Year ago EPS-1.07-0.81-3.75-2.76
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate320k480k1.51M3.94M
Low estimate240k360k1.21M2.19M
High estimate400k600k1.8M5.7M
Year ago sales463kN/A1.5M1.51M
Sales growth (year/est)-30.90%N/A0.50%160.90%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.3-1.01-1.14-0.67
Actual EPS-1.07-0.81-2.12-1.13
Difference0.230.2-0.98-0.46
Surprise %17.70%19.80%-86.00%-68.70%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.56-0.55-2.76-2.1
7 days ago-0.56-0.55-2.76-2.1
30 days ago-0.6-0.58-2.39-1.98
60 days ago-0.61-0.51-3.01-2.43
90 days ago-0.61-0.51-3.01-2.43
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days11N/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesOCXIndustrySector(s)S&P 500
Current qtr.47.70%N/AN/AN/A
Next qtr.32.10%N/AN/AN/A
Current year26.40%N/AN/AN/A
Next year23.90%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A